Regenerative Medical Technology Group Inc. (RMTG)
OTCMKTS · Delayed Price · Currency is USD
0.0400
+0.0186 (86.92%)
Jul 9, 2026, 12:32 PM EST
RMTG Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 6.38 | 5.1 | 4.11 | 2.41 | 1.53 | 0.44 | |
Revenue Growth (YoY) | 36.96% | 24.17% | 70.44% | 57.49% | 249.46% | 694.97% |
Cost of Revenue | 2.74 | 2.29 | 1.28 | 0.73 | 0.65 | 0.29 |
Gross Profit | 3.63 | 2.81 | 2.82 | 1.68 | 0.88 | 0.15 |
Selling, General & Admin | 3.98 | 3.32 | 2.47 | 2.07 | 1.72 | 9.93 |
Operating Expenses | 4.3 | 3.6 | 2.69 | 2.38 | 1.87 | 9.97 |
Operating Income | -0.67 | -0.79 | 0.13 | -0.71 | -0.99 | -9.82 |
Interest Expense | -8.74 | -7.45 | -5.64 | -6.49 | -4.4 | -2.72 |
Other Non Operating Income (Expenses) | 1.9 | 0.84 | -0.05 | -0 | -0.18 | -0.1 |
EBT Excluding Unusual Items | -7.51 | -7.4 | -5.56 | -7.2 | -5.58 | -12.64 |
Impairment of Goodwill | - | - | - | -4.13 | - | - |
Legal Settlements | - | - | - | - | - | -0.23 |
Other Unusual Items | -0.42 | -0.42 | - | 1.51 | - | - |
Pretax Income | -7.93 | -7.81 | -5.56 | -9.81 | -5.58 | -12.87 |
Earnings From Continuing Operations | -7.93 | -7.81 | -5.56 | -9.81 | -5.58 | -12.87 |
Earnings From Discontinued Operations | - | - | - | - | 0.07 | -0.01 |
Net Income | -7.93 | -7.81 | -5.56 | -9.81 | -5.51 | -12.88 |
Net Income to Common | -7.93 | -7.81 | -5.56 | -9.81 | -5.51 | -12.88 |
Shares Outstanding (Basic) | 13 | 13 | 13 | 12 | 12 | 11 |
Shares Outstanding (Diluted) | 13 | 13 | 13 | 12 | 12 | 11 |
Shares Change (YoY) | 1.93% | 0.82% | 0.68% | 1.86% | 6.42% | 22.91% |
EPS (Basic) | -0.62 | -0.62 | -0.44 | -0.79 | -0.45 | -1.12 |
EPS (Diluted) | -0.62 | -0.62 | -0.44 | -0.79 | -0.45 | -1.12 |
Free Cash Flow | -1.58 | -1.31 | 0.64 | -0.8 | -1.31 | -9.88 |
Free Cash Flow Per Share | -0.12 | -0.10 | 0.05 | -0.07 | -0.11 | -0.86 |
Gross Margin | 56.99% | 55.11% | 68.73% | 69.53% | 57.31% | 34.29% |
Operating Margin | -10.52% | -15.43% | 3.25% | -29.30% | -64.99% | -2242.37% |
Profit Margin | -124.36% | -153.17% | -135.44% | -407.21% | -359.87% | -2942.42% |
Free Cash Flow Margin | -24.77% | -25.67% | 15.47% | -33.40% | -85.78% | -2255.99% |
EBITDA | -0.34 | -0.51 | 0.35 | -0.4 | -0.84 | -9.78 |
EBITDA Margin | -5.39% | -9.92% | 8.62% | -16.44% | -55.01% | - |
D&A For EBITDA | 0.33 | 0.28 | 0.22 | 0.31 | 0.15 | 0.04 |
EBIT | -0.67 | -0.79 | 0.13 | -0.71 | -0.99 | -9.82 |
EBIT Margin | -10.52% | -15.43% | 3.25% | -29.30% | -64.99% | - |
Advertising Expenses | - | 0.72 | 0.46 | 0.48 | 0.32 | 0.13 |